Xcout Intel
For The Biome, LLC
The OpenBiome Foundation expands patient access to microbiome therapies and drives scientific discovery to advance human health. The organization provides resources, strategic collaborations, and investments to equip clinicians, researchers, and healthcare systems with tools for microbiome-directed treatments.
Subscribe to see For The Biome, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
For The Biome, LLC at a glance
For The Biome, LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $2.9M in April 2022. Xcout tracks 9 named people at For The Biome, LLC, including Julie Barrett O’Brien (Foundation CEO).
For The Biome, LLC leadership
- Julie Barrett O’BrienFoundation CEO
- Jim BildnerCEO Draper Richards Kaplan Foundation
- Ruchika KumarGeneral Counsel, Head of People N-Power Medicine
- Jane WilliamsChair
- Joanne KamensVice Chair
- Stephen JonesExecutive Director Stanley Family Foundation
3 more named people on record for For The Biome, LLC, with roles, board committees and tenure — see the full roster →
For The Biome, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
For The Biome, LLC competitors
A few of For The Biome, LLC's closest competitors — see the full list of competitors and alternatives →
Anto Biosciences is a frontier biology AI lab founded in 2025, focusing on developing a foundation model for microbial communities.
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Opal Biosciences (operating as Opal Therapeutics) is a biotechnology company that develops patient-derived uterine organoids to model human reproductive biology. The company provides research and drug discovery platforms to help researchers study conditions like endometriosis and uterine fibroids, serving the biotechnology and pharmaceutical research sectors.
Codebreaker Bioscience is a privately held bioscience platform startup founded in 2023 that develops microbiome-related solutions and is based in Chile.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Get For The Biome, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on For The Biome, LLC in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access